Citations (26)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Rui-Feng Liang, Wen-Jing Ge, Xian-Mei Song, Jun-Ping Zhang, Wei-Feng Cui, She-Feng Zhang & Geng-Sheng Li. (2020) Involvement of organic anion-transporting polypeptides and organic cation transporter in the hepatic uptake of jatrorrhizine. Xenobiotica 50:4, pages 479-487.
Read now
Read now
Nuggehally R. Srinivas. (2016) Interspecies scaling of excretory amounts using allometry – retrospective analysis with rifapentine, aztreonam, carumonam, pefloxacin, miloxacin, trovafloxacin, doripenem, imipenem, cefozopran, ceftazidime, linezolid for urinary excretion and rifapentine, cabotegravir, and dolutegravir for fecal excretion. Xenobiotica 46:9, pages 784-792.
Read now
Read now
R. J. Riley, S. A. Foley, P. Barton, M. G. Soars & B. Williamson. (2016) Hepatic drug transporters: the journey so far. Expert Opinion on Drug Metabolism & Toxicology 12:2, pages 201-216.
Read now
Read now
Donna A. Volpe. (2016) Transporter assays as useful in vitro tools in drug discovery and development. Expert Opinion on Drug Discovery 11:1, pages 91-103.
Read now
Read now
Articles from other publishers (22)
Eleanor Jing Yi Cheong, Daniel Zhi Wei Ng, Sheng Yuan Chin, Ziteng Wang & Eric Chun Yong Chan. (2022) Application of a physiologically based pharmacokinetic model of rivaroxaban to prospective simulations of drug–drug–disease interactions with protein kinase inhibitors in cancer‐associated venous thromboembolism. British Journal of Clinical Pharmacology 88:5, pages 2267-2283.
Crossref
Crossref
Jan Stephan Bolten, Anna Pratsinis, Claudio Luca Alter, Gert Fricker & Jörg Huwyler. (2022)
Zebrafish (
Danio rerio
) larva as an in vivo vertebrate model to study renal function
. American Journal of Physiology-Renal Physiology 322:3, pages F280-F294.
Crossref
Crossref
Bret BernerRichard N. Upton, Ashley M. Hopkins, Ahmad Y. Abuhelwa, Jim H. Hughes & David J.R. Foster. 2021. Drug Delivery Approaches. Drug Delivery Approaches
43
73
.
Rajesh Chopra & Florence I. Raynaud. 2020. Phase I Oncology Drug Development. Phase I Oncology Drug Development
45
69
.
Bo Feng, Mark West, Nandini C. Patel, Travis Wager, Xinjun Hou, Jillian Johnson, Larry Tremaine & Jennifer Liras. (2019) Validation of Human MDR1-MDCK and BCRP-MDCK Cell Lines to Improve the Prediction of Brain Penetration. Journal of Pharmaceutical Sciences 108:7, pages 2476-2483.
Crossref
Crossref
Yoichi NaritomiSeigo Sanoh & Shigeru Ohta. (2019) Utility of Chimeric Mice with Humanized Liver for Predicting Human Pharmacokinetics in Drug Discovery: Comparison with <i>in Vitro</i>–<i>in Vivo</i> Extrapolation and Allometric Scaling. Biological and Pharmaceutical Bulletin 42:3, pages 327-336.
Crossref
Crossref
Mary C. Regier & Kelly R. Stevens. 2019. Biofabrication and 3D Tissue Modeling. Biofabrication and 3D Tissue Modeling
253
278
.
Gabriela I. Patilea-Vrana & Jashvant D. Unadkat. (2018) When Does the Rate-Determining Step in the Hepatic Clearance of a Drug Switch from Sinusoidal Uptake to All Hepatobiliary Clearances? Implications for Predicting Drug-Drug Interactions. Drug Metabolism and Disposition 46:11, pages 1487-1496.
Crossref
Crossref
Tom De Bruyn, Ayşe Ufuk, Carina Cantrill, Rachel E. Kosa, Yi-an Bi, Mark Niosi, Sweta Modi, A. David Rodrigues, Larry M. Tremaine, Manthena V. S. Varma, Aleksandra Galetin & J. Brian Houston. (2018) Predicting Human Clearance of Organic Anion Transporting Polypeptide Substrates Using Cynomolgus Monkey: In Vitro–In Vivo Scaling of Hepatic Uptake Clearance. Drug Metabolism and Disposition 46:7, pages 989-1000.
Crossref
Crossref
Deanna J. Brackman & Kathleen M. Giacomini. (2018)
Reverse Translational Research of
ABCG2
(BCRP) in Human Disease and Drug Response
. Clinical Pharmacology & Therapeutics 103:2, pages 233-242.
Crossref
Crossref
David M. Burger, Lindsey H. M. te Brake & Rob E. Aarnoutse. 2018. Drug Interactions in Infectious Diseases: Mechanisms and Models of Drug Interactions. Drug Interactions in Infectious Diseases: Mechanisms and Models of Drug Interactions
15
47
.
Mariana Matias, Ana Fortuna, Joana Bicker, Samuel Silvestre, Amílcar Falcão & Gilberto Alves. (2017) Screening of pharmacokinetic properties of fifty dihydropyrimidin(thi)one derivatives using a combo of in vitro and in silico assays. European Journal of Pharmaceutical Sciences 109, pages 334-346.
Crossref
Crossref
Matthew M. Weiss, Thomas A. Dineen, Isaac E. Marx, Steven Altmann, Alessandro Boezio, Howard Bregman, Margaret Chu-Moyer, Erin F. DiMauro, Elma Feric Bojic, Robert S. Foti, Hua Gao, Russell Graceffa, Hakan Gunaydin, Angel Guzman-Perez, Hongbing Huang, Liyue Huang, Michael Jarosh, Thomas Kornecook, Charles R. Kreiman, Joseph Ligutti, Daniel S. La, Min-Hwa Jasmine Lin, Dong Liu, Bryan D. Moyer, Hanh N. Nguyen, Emily A. Peterson, Paul E. Rose, Kristin Taborn, Beth D. Youngblood, Violeta Yu & Robert T. FremeauJr.Jr.. (2017)
Sulfonamides as Selective Na
V
1.7 Inhibitors: Optimizing Potency and Pharmacokinetics While Mitigating Metabolic Liabilities
. Journal of Medicinal Chemistry 60:14, pages 5969-5989.
Crossref
Crossref
Russell F. Graceffa, Alessandro A. Boezio, Jessica Able, Steven Altmann, Loren M. Berry, Christiane Boezio, John R. Butler, Margaret Chu-Moyer, Melanie Cooke, Erin F. DiMauro, Thomas A. Dineen, Elma Feric Bojic, Robert S. Foti, Robert T. FremeauJr.Jr., Angel Guzman-Perez, Hua Gao, Hakan Gunaydin, Hongbing Huang, Liyue Huang, Christopher Ilch, Michael Jarosh, Thomas Kornecook, Charles R. Kreiman, Daniel S. La, Joseph Ligutti, Benjamin C. Milgram, Min-Hwa Jasmine Lin, Isaac E. Marx, Hanh N. Nguyen, Emily A. Peterson, Gwen Rescourio, John Roberts, Laurie Schenkel, Roman Shimanovich, Brian A. Sparling, John Stellwagen, Kristin Taborn, Karina R. Vaida, Jean Wang, John Yeoman, Violeta Yu, Dawn Zhu, Bryan D. Moyer & Matthew M. Weiss. (2017)
Sulfonamides as Selective Na
V
1.7 Inhibitors: Optimizing Potency, Pharmacokinetics, and Metabolic Properties to Obtain Atropisomeric Quinolinone (AM-0466) that Affords Robust in Vivo Activity
. Journal of Medicinal Chemistry 60:14, pages 5990-6017.
Crossref
Crossref
Christopher J. Helal, Eric P. Arnold, Tracey L. Boyden, Cheng Chang, Thomas A. Chappie, Kimberly F. Fennell, Michael D. Forman, Mihaly Hajos, John F. Harms, William E. Hoffman, John M. Humphrey, Zhijun Kang, Robin J. Kleiman, Bethany L. Kormos, Che-Wah Lee, Jiemin Lu, Noha Maklad, Laura McDowell, Scot Mente, Rebecca E. O’Connor, Jayvardhan Pandit, Mary Piotrowski, Anne W. Schmidt, Christopher J. Schmidt, Hirokazu Ueno, Patrick R. Verhoest & Edward X. Yang. (2017) Application of Structure-Based Design and Parallel Chemistry to Identify a Potent, Selective, and Brain Penetrant Phosphodiesterase 2A Inhibitor. Journal of Medicinal Chemistry 60:13, pages 5673-5698.
Crossref
Crossref
Ayman F. El‐Kattan. 2017. Oral Bioavailability Assessment. Oral Bioavailability Assessment
309
329
.
Stefanie D. Krämer, Hélène E. Aschmann, Maja Hatibovic, Katharina F. Hermann, Claudia S. Neuhaus, Cyrill Brunner & Sara Belli. (2016) When barriers ignore the “rule-of-five”. Advanced Drug Delivery Reviews 101, pages 62-74.
Crossref
Crossref
Martijn J. Wilmer, Chee Ping Ng, Henriëtte L. Lanz, Paul Vulto, Laura Suter-Dick & Rosalinde Masereeuw. (2016) Kidney-on-a-Chip Technology for Drug-Induced Nephrotoxicity Screening. Trends in Biotechnology 34:2, pages 156-170.
Crossref
Crossref
Rachel Rogers Worley & Jeffrey Fisher. (2015) Application of physiologically-based pharmacokinetic modeling to explore the role of kidney transporters in renal reabsorption of perfluorooctanoic acid in the rat. Toxicology and Applied Pharmacology 289:3, pages 428-441.
Crossref
Crossref
Manthena V. Varma, Stefanus J. Steyn, Charlotte Allerton & Ayman F. El-Kattan. (2015) Predicting Clearance Mechanism in Drug Discovery: Extended Clearance Classification System (ECCS). Pharmaceutical Research 32:12, pages 3785-3802.
Crossref
Crossref
Steve O’Hagan & Douglas B. Kell. (2015) The apparent permeabilities of Caco-2 cells to marketed drugs: magnitude, and independence from both biophysical properties and endogenite similarities. PeerJ 3, pages e1405.
Crossref
Crossref
Douglas B. Kell & Stephen G. Oliver. (2014) How drugs get into cells: tested and testable predictions to help discriminate between transporter-mediated uptake and lipoidal bilayer diffusion. Frontiers in Pharmacology 5.
Crossref
Crossref